✦ LIBER ✦

Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma

✍ Scribed by John Glaspy; Michael B. Atkins; Jon M. Richards; Sanjiv S. Agarwala; Steven O'Day; Robert D. Knight; J. Ulf Jungnelius; Agop Y. Bedikian

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 269 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24576

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a multicenter, randomized, do

Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma

✍ Tim Eisen; Uwe Trefzer; Anne Hamilton; Peter Hersey; Michael Millward; Robert D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 2 views

A study of paclitaxel, carboplatin, and

A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma : A phase 2 Consortium study

✍ Gary A. Croghan; Vera J. Suman; William J. Maples; Mark Albertini; Gerald Linett 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Abatacept in the treatment of patients w

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

✍ Philip Mease; Mark C. Genovese; Geoffrey Gladstein; Alan J. Kivitz; Christopher 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

✍ Oliver Distler; Wolfgang Eich; Eva Dokoupilova; Zdenek Dvorak; Martin Fleck; Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views